SCHEMBL7282009

SCHEMBL7282009

CCCC[S+]([O-])c1ccc(C(Cl)C(N)=O)cc1

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP13 P45452 1/20 0.33
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.30
HTT P42858 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7282154 0.77 EPHX1 (0.32)
SCHEMBL7435723 0.75 CHRM2 (0.32) LMNA
SCHEMBL10933393 0.74 HSD17B3 (0.39) LMNATSHR
SCHEMBL7290900 0.74 ALDH1A1 (0.54) CA1CA2HPGD
SCHEMBL10837604 0.74 OPRD1 (0.37)
SCHEMBL7282803 0.72 THRB (0.42) MMP13CA1CA2
SCHEMBL7289270 0.72 ESR1 (0.44) LMNATSHR
SCHEMBL14918867 0.72 ALDH1A1 (0.48) TSHRCA2
SCHEMBL24844527 0.71 MAPT (0.39) LMNATSHRCA1CA2
SCHEMBL7282093 0.71 MAPT (0.39) LMNATSHRCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4567264-A ADRENERGIC BLOCKING AGENTS SYNTEX (U.S.A.) INC. (US) 1986-01-28 US disclosed
US-4558129-A Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade SYNTEX (U.S.A.) INC. (US) 1985-12-10 US disclosed
US-4499100-A CARDIOUVASCULAR DISORDERS SYNTEX (U.S.A.) INC. (US) 1985-02-12 US disclosed
EP-0126449-A1 Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry SYNTEX (U.S.A.) INC. (US) 1984-11-28 EP disclosed